Strategy implementation
Policy, charter, manual review & approval
Stakeholder activity
Corporate governance
Board activities in FY2025/26
February
Ordinary Board meeting to review and consider:
- MD’s quarterly update to the Board
- Committee reports for Q3 ending 31 March 2026
- Fund’s representation of its Investee companies Board of Directors
- Update on Board activities
- Confirmation of previous meeting minutes
- Joint Board – management FY2026/27 strategy
- brainstorming session
March
Special Board meeting reviewed and considered:
- SACA recommendations on the proposed staff contract extensions and renewals
- Appointment of a select committee to consider the Board remuneration survey and recommendations
April
- Board strategy retreat (to consider
- management work plans FY2026/27)
May
Ordinary Board meeting to review and consider:
- MD’s quarterly update
- Approval of the final Fund Strategy for FY2026/27
- Committee reports for quarter 3 ending 31 March 2026
- Report of the special committee on the Fund’s representation on its investee companies’ Board of Directors
June
Special Board meeting reviewed and considered:
- Fund/Managing Director’s Scorecard for FY2026/27
- Revised Fund Budget for FY2026/27
- Hi-Innovator 2 Programme Business case
- International Labour Conference – Geneva
The Board is supported by four committees: Staff Administration and Corporate Affairs Committee (SACA), Finance Committee, Investments and Project Monitoring Committee (IPMC) and the Audit and Risk Assurance Committee (ARC). The Board appointed a Special Committee on Investee Companies’ Board Representation to focus on identifying suitable Fund representatives on the Boards of Directors of Investee Companies that the Fund invests in, as applicable. Focus areas for these committees are contained in individual committee reports.